260 related articles for article (PubMed ID: 25236910)
1. AXIN1 and AXIN2 variants in gastrointestinal cancers.
Mazzoni SM; Fearon ER
Cancer Lett; 2014 Dec; 355(1):1-8. PubMed ID: 25236910
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
3. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
4. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
5. Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer.
Rosales-Reynoso MA; Saucedo-Sariñana AM; Contreras-Díaz KB; Márquez-González RM; Barros-Núñez P; Pineda-Razo TD; Marin-Contreras ME; Durán-Anguiano Ó; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
Tohoku J Exp Med; 2019 Nov; 249(3):173-183. PubMed ID: 31723073
[TBL] [Abstract][Full Text] [Related]
6. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
[TBL] [Abstract][Full Text] [Related]
8. Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.
Zhang Y; Liang B; Song X; Wang H; Evert M; Zhou Y; Calvisi DF; Tang L; Chen X
Am J Pathol; 2021 May; 191(5):930-946. PubMed ID: 33545120
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin signaling in hepatocellular carcinoma.
Xu C; Xu Z; Zhang Y; Evert M; Calvisi DF; Chen X
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166233
[TBL] [Abstract][Full Text] [Related]
10. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.
Figeac N; Zammit PS
Cell Signal; 2015 Aug; 27(8):1652-65. PubMed ID: 25866367
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
12. Conditional disruption of Axin1 leads to development of liver tumors in mice.
Feng GJ; Cotta W; Wei XQ; Poetz O; Evans R; Jardé T; Reed K; Meniel V; Williams GT; Clarke AR; Dale TC
Gastroenterology; 2012 Dec; 143(6):1650-9. PubMed ID: 22960659
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.
Li VS; Ng SS; Boersema PJ; Low TY; Karthaus WR; Gerlach JP; Mohammed S; Heck AJ; Maurice MM; Mahmoudi T; Clevers H
Cell; 2012 Jun; 149(6):1245-56. PubMed ID: 22682247
[TBL] [Abstract][Full Text] [Related]
15. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
[TBL] [Abstract][Full Text] [Related]
16. Nuclear AXIN2 represses MYC gene expression.
Rennoll SA; Konsavage WM; Yochum GS
Biochem Biophys Res Commun; 2014 Jan; 443(1):217-22. PubMed ID: 24299953
[TBL] [Abstract][Full Text] [Related]
17. Alterations of axis inhibition protein 1 (AXIN1) in hepatitis B virus-related hepatocellular carcinoma and overexpression of AXIN1 induces apoptosis in hepatocellular cancer cells.
Li J; Quan H; Liu Q; Si Z; He Z; Qi H
Oncol Res; 2013; 20(7):281-8. PubMed ID: 23879168
[TBL] [Abstract][Full Text] [Related]
18. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling.
Zhang R; Li S; Schippers K; Li Y; Eimers B; Lavrijsen M; Wang L; Cui G; Chen X; Peppelenbosch MP; Lebbink JHG; Smits R
Cancer Res; 2024 May; 84(9):1443-1459. PubMed ID: 38359148
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.
White BD; Chien AJ; Dawson DW
Gastroenterology; 2012 Feb; 142(2):219-32. PubMed ID: 22155636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
